Conference Highlights

Biochemistry and Molecular Biology

The section of ocular biochemistry studies the biochemical, immunological, and genetic aspects of eye diseases. For nearly a decade, recombinant DNA technology has been effectively used on the lens, and it is now having an influence on other ocular tissues including the retina. In the future years, molecular breakthroughs in clinical ophthalmology will have a greater impact on elements of diagnosis, prognosis, and therapy. Molecular technology is currently revolutonising diagnostic tests in ophthalmology for both acquired and inherited illnesses. The molecular genetics of eye disease is currently being studied extensively using gene mapping and isolation approaches. Rapid progress in understanding the molecular basis of eye illnesses will help to develop eye disease treatment, including gene therapy.

•    Neurochemistry
•    Bioorganic chemistry
•    Clinical biochemistry, physical biochemistry
•    Molecular genetics
•    Biochemical pharmacology and Immunochemistry

Market Analysis:
The global biochemistry analyzers market is poised to grow from nearly US$ 3200 Mn within the year 2017 to concerning US$ 4,700 Mn by the top of 2024. This represents a CAGR of 5.5% over the forecast amount.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cataract

A cataract is a clouded or opaque part of the ocular lens. Proteins and fibres in the lens begin to break down, resulting in blurry or confused vision. The location and size of the cataract will affect your eyesight. At first, stronger illumination and spectacles can assist you deal with cataracts. Changes in metabolism and nutrient flow in the lens cause cataracts to form. Cataracts are most commonly degenerative, although they can also be congenital or result from infection, radiation, medications, trauma, or diabetes mellitus. N-Acetylcarnosine drops have been studied as a medical treatment for cataracts, as has Femtosecond laser mode-locking during cataract surgery, and the use of stem cells in a clinical trial for lens regeneration.

•   IOL Implantation
•   Surgical Techniques
•   Operational Complications
•   Infection Prophylaxis
•   Cataract and Refractive Surgery

Market Analysis:
At 3.1% CAGR, The "Cataract Surgery Device Market" Size is expected to grow from 3524.3 million USD In 2020, to reach 3643.2 Million USD by 2026, The base year considered for the study is 2021, and the forecast period is between 2022 and 2026.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Clinical and Epidemiologic Research

What makes this study so vital? Clinical trials are crucial in the development of new treatments for eye illness, ensuring that they are safe, effective, and beneficial to patients.

These studies result in medical advances and better techniques to help people maintain their vision. In recent years, major improvements in ophthalmology clinical research have been made. Gene therapy, immunomodulation, and regenerative medicine are now among the topics being researched. Patients in the field of ophthalmology will have more diagnostic and treatment choices as a result. The majority of contemporary ophthalmology clinical studies are focusing on patients with retinopathy, macular degeneration, uveitis, glaucoma, and cataracts. The goal of epidemiology is to describe the distribution and scale of illness problems, as well as to determine the etiological elements that contribute to disease pathogenesis. Epidemiology strives to explain the scope and distribution of disease issues, uncover etiological elements in disease pathogenesis, and provide data for the design, implementation, and assessment of disease preventive, control, and treatment services.

Principles of Clinical Research and Methodology
Drug Development Process
Adverse Events and Unanticipated Problems
Genetic Epidemiology
Biostatistics
Clinical epidemiology

Market Analysis:

The clinical trials market is projected to reach USD 52.0 billion by 2026 from USD 38.7 billion in 2021, at a CAGR of 6.1% during the forecast period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Clinical ophthalmology

Clinical ophthalmology diagnoses and operates on eyes. Clinical procedures can diagnose a wide range of illnesses and ailments from the eye. It is mostly concerned in research and clinical findings of various eye diseases, as well as procedures related to ophthalmic patient care. Clinical research on a wide range of eye illnesses is included in the studies.

Ophthalmic surgical studies
Translational research
Ocular therapeutics
Experimental ophthalmology
Optometry innovations

Market Analysis:

The Global Ophthalmology Market size was estimated at USD 52.07 billion in 2020, is expected to reach USD 55.28 billion in 2021, and is projected to grow at a CAGR of 6.52% to reach USD 81.05 billion by 2027.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Cornea

Cornea is responsible for transferring light into the back of the eye and hence plays a crucial part in concentrating your vision. It aids in the protection of the eye against infection and foreign matter. The cornea can be damaged by diseases and trauma to the eyes. Infections, trauma, allergies, and other factors are all common causes of corneal disease. Protecting the structures inside the eye, contributing to the refractive power of the eye, and concentrating light rays on the retina with minimal dispersion and optical degradation are all important roles of the cornea. Corneal disease is a dangerous disorder that can result in clouding, distortion, scarring, and, in the worst-case scenario, blindness.

Corneal Scope and Imaging
Corneal Disease and Treatment
Laser Keratoplasty
Corneal Transplantation
Diagnosis and Tests

Market Analysis:

The corneal transplantation market is projected to reach $640.79 million by 2028 from $420.71 million in 2021; it is estimated to grow at a CAGR of 6.2% during 2021-2028.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Diabetic Retinopathy

The most prevalent microvascular ocular consequence of diabetes is diabetic retinopathy (DR). It's now known to be an inflammatory neurovascular consequence, with neuronal injury/dysfunction occurring before clinical microvascular damage. Importantly, the same pathophysiologic mechanisms that damage the pancreatic -cell (e.g., inflammation, epigenetic changes, insulin resistance, fuel excess, and abnormal metabolic environment) also cause cell and tissue damage, increasing the risk of all complications, including diabetic retinopathy. Over the last decade, treatments for diabetic macular edoema (DME) and proliferative diabetic retinopathy (PDR), two vision-threatening consequences of diabetes, have vastly improved.

•   Symptoms and causes
•   Diagnosis and tests
•   Management and treatment
•   Prognosis
•   Surgery indications

Market Analysis:
The global diabetic retinopathy market was valued at $966 million in 2015, and is expected to reach $2,490 million by 2022, growing at a CAGR of 14.4% during the forecast period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

External Eye Disease

Corneal and external illnesses are ailments that affect the outside layer of the eye. Dry eye, blepharitis, allergies, conjunctivitis, corneal infections, and corneal dystrophies, all of which can produce clouding of the cornea, are some of the most frequent ocular surface diseases. The exterior of the eye is vulnerable to infections and injuries because it is in direct touch with the environment. The outer eye can also be affected by a number of genetic illnesses. Redness, inflammation, watering, and hazy vision are all common symptoms of external eye illness.

•   Symptoms
•   Diagnosis
•   Prevention
•   Eye Disorders

Market Analysis:
The dry eye disease market is valued at USD 5,209.05 million in 2021 and is expected to register a CAGR of nearly 5.12% over the forecast period. The global dry eye medication market is expected to grow from $7.63 billion in 2021 to $8.62 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The market is expected to reach $13.27 billion in 2026 at a CAGR of 11.4%. The global dry eye syndrome market reached a value of US$ 4.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 6 Billion by 2027, exhibiting a CAGR of 5.95% during 2022-2027.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Eye Anatomy

Prior to doing an examination, it is crucial to understand the anatomy of the eye. Although our eyes are small, they provide us with vision, which many people regard to be the most crucial of our senses. The sclera is a strong white coating that covers much of the outside of the eye. The sclera is covered by a thin clear covering called the conjunctiva. The cornea is a clear, window-like surface at the very front of the eye that protects the pupil and iris behind that window.
The colourful component of the eye, the iris, is a muscle that contracts and expands to admit light into the eye. The pupil is a hole in the middle of the iris that allows light to enter the eye (it is covered by the transparent cornea).
Our eye's lens focuses this light onto the retina, which is located in the rear of the eye. The retina turns light images into electrical signals, which are then transmitted to the brain via the optic nerve by the retina's nerve cells and fibres. The optic disc is the part of the retina where all of the nerve fibres join to form the optic nerve as it exits the eye and connects to the brain.

•   Anatomy & Physiology
•   Structure Of Eye
•   Functions
•   Role and Mechanism

Market Analysis:
The global Eye Anatomical Model market size is estimated to be worth USD 3 million in 2022 and is forecast to a readjusted size of USD 3 million by 2028 with a CAGR of 1.9% during the review period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Eye Infections and Allergies

Every day, millions of individuals wear contact lenses safely. However, they pose a danger of causing an eye infection. Infections of the eyeball and associated tissues, including the clear front surface of the eye (cornea) and the thin membrane covering the outer and inner eyelids, arise when harmful microorganisms — bacteria, fungi, and viruses — penetrate any part of the eyeball or surrounding tissues (conjunctiva). Various eye solutions can help reduce inflammation and discomfort. The practitioner should make a fast diagnosis and begin appropriate treatment to achieve a favourable visual outcome for the patient. The most frequent types of allergic conjunctivitis in the eyes are seasonal allergic conjunctivitis (hay fever conjunctivitis) and year-round or perennial allergic conjunctivitis (atopic conjunctivitis, atopic keratoconjunctivitis). Allergic reactions, such as those produced by airborne allergens, can irritate the conjunctiva. Itching, redness, swelling, tearing, and stringy discharge are all common symptoms.

•   Causes and Symptoms
•   Risk Factors
•   Diagnosis
•   Treatment

Market Analysis:
The global Eye Infections Treatment Market is estimated at US$ 7.3 Bn for 2022, and the market is projected to progress at a CAGR of 3.8% from 2022 to 2030. Demand for eye infections treatment is anticipated to reach a worth of US$ 9.9 Bn by the end of 2030.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Glaucoma

Glaucoma is a set of eye illnesses that damage the optic nerve, a nerve in the back of the eye that can cause vision loss and blindness. It is characterised by the death of retinal ganglion cells in the eye over time, culminating in irreversible vision loss. We now have powerful medicines that can drastically reduce the progression of glaucoma by lowering ocular pressure, thanks to research. Glaucoma is the primary cause of permanent blindness globally, owing to the fact that many people do not notice symptoms until the disease has progressed. Furthermore, even when very low ocular pressure is reached, some persons with severe glaucoma continue to decline. This is why it's critical to do research to better our scientific understanding of the condition and discover novel remedies.

•   Risk Factors
•   Marijuana and glaucoma
•   Causes and Symptoms
•   Diagnosis
•   Treatment

Market Analysis:
The glaucoma market is expected to grow from $2.85B in 2020 to $3.48B in 2030, a CAGR of 2%. The US is the biggest market of the 7MM, accounting for 75.0% market share in 2020. This is set to increase to 80.2% by 2030.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Immunology and Microbiology

Ocular microbiology remains an applied science. Advances in molecular biology, as well as modern technologies, are paving the way for a better understanding of ocular illnesses. Infectious illness research progresses at a breakneck pace. The advancements have made significant changes to the treatment and possibly eradication of many forms of eye infections. Ocular immunology is a highly specialised field of medicine that deals with the diagnosis and treatment of inflammatory eye disorders. These disorders can cause minor vision loss or severe vision loss. Ocular tissues' immunological and molecular systems prevent or resolve inflammation while maintaining homeostasis.

•   Ocular infections
•   Ocular pathogens
•   Systemic Interactions
•   Contact lenses and allergy
•   Types of Eye inflammation

Market Analysis:
The global Immunology market size is poised to grow by $ 55.00 bn during 2021-2025, progressing at a CAGR of 8.45% during the forecast period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Lens Disorder

It's a pathologic condition of the eye's translucent biconvex body, which sits between the posterior chamber and the vitreous body or lens. The ciliary body is in charge of lens focusing. The lens is narrower and focuses light rays from distant objects when the ciliary body is relaxed. The lens zonules relax and the lens takes on a more spherical shape when the ciliary muscle contracts. This permits the lens to focus on objects that are close to it. Age-related eye illnesses such as age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma are the primary causes of blindness and impaired vision.

•   Causes and Symptoms
•   Risk Factors
•   Diagnosis
•   Treatment

Market Analysis:
The Eye Allergy Treatment market revenue was Million USD in 2016, grew to Million USD in 2022, and will reach Million USD in 2029, with a CAGR of during 2022-2029.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Nano Ophthalmology

Nanotechnology is a new concept that will soon become the pinnacle of science and technology. This technology is predicted to benefit various parts of ophthalmology therapy and diagnostics in the near future. Many medications' bioavailability is reduced due to the complicated drug delivery barrier in the eye, resulting in poor therapeutic benefits. New medications must be investigated using proper delivery methods and vehicles. Nanotechnology has been used to develop prospective ocular medication delivery systems that interact with the ocular mucosa, enhance permeability, and lengthen drug retention time in the eye. Nano-carriers such as liposomes, nanoparticles, nano-suspensions, nano-micelles, and nano-emulsions have also gained favour as effective theranostic applications to treat various microbial superbugs. Nanocarrier technologies hold a lot of promise for revolutionising medication delivery in DED, as they can deliver therapeutic agents to particular locations and for longer periods of time.

•   Utility & Risks of Therapeutic Nanotechnology
•   Nanomedicine and its role
•   Applications of nanoparticles
•   Recent advancements
•   Considerations

Market Analysis:
The global nanomedicine market is expected to grow from $221.12 billion in 2021 to $252.50 billion in 2022 at a compound annual growth rate (CAGR) of 14.2%. It is expected to reach $414.97 billion in 2026 at a CAGR of 13.2%.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Neuro Ophthalmology

The field of neuro-ophthalmology is concerned with the diagnosis and treatment of visual diseases caused by the nervous system. It involves particular training and competence in illnesses of the eye, brain, nerves, and muscles, as it is a specialisation of both neurology and ophthalmology. Finding substantial intracranial meningioma pathology may require recognising minor physical indications such pupil irregularities, cranial nerve palsies, or vision field deficits. A detailed understanding of neuroanatomy and neuro-ophthalmologic evaluation is required for accurate diagnosis and referral to neuroimaging.

•   Neuroimaging
•   Clinical neuroscience
•   Disorders
•   Hereditary Optic Neuropathy
•   Pediatric Neuro-Ophthalmology

Market Analysis:
The global medical equipment market grew from $384 billion in 2015 to $456.7 billion in 2020 at a CAGR of 3.52%. The global medical equipment market is expected to grow from $456.7 billion in 2020 to $662.26 billion in 2025 at a CAGR of 7.71%.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Ocular Inflammation

Ocular inflammation is a common side effect after eye surgery, and it can lead to complications including macular cystoid edoema. Pharmacologic therapy and less invasive surgical procedures are frequently used to treat it. Ocular inflammation has become a hot topic in ophthalmology, encompassing internal medicine, surgery, fundamental research, physiology, pharmacology, microbiology, immunology, rheumatology, pharmacology, and laboratory medicine. The orbit, ocular adnexa, ocular surface, conjunctiva, cornea, sclera, uvea, retinal vessels, and optic nerve are all affected by ocular inflammatory disorders. The origin and prognosis of ocular inflammation range from benign, self-limited illnesses to organ-threatening disorders, posing diagnostic and therapeutic problems.

•   Grand Challenges
•   Causes and Symptoms
•   Risk Factors
•   Diagnosis
•   Treatment

Market Analysis:
The global Ocular Inflammation Treatment market size is projected to reach USD 21460 million by 2026, from USD 20230 million in 2020, at a CAGR of 5.5%% during 2021-2026.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Ocular Oncology

All malignancies involving the eye, eyelid, orbit, and tear, or lacrimal, glands are managed by ocular oncology, or eye cancer, services. Some of them are benign, while others are cancerous and aggressive. The most effective approaches to prevent and treat eye cancers are investigated in ocular oncology research. On the eyelid, orbit, cornea, conjunctiva, iris, retina, or optic nerve, eye tumours can develop as a primary or metastatic tumour. Ocular oncology research, often known as eye cancer research, focuses on the best ways to prevent and treat eye cancer. Novel diagnostic tests, surgical treatments, radiation therapy, and chemotherapy, as well as targeted genetic therapies including the creation of new anti-angiogenic drugs, are all possibilities.

•   Advance Patient care
•   Challenges
•   Adverse events
•   Disorders
•   Diagnosis and Treatment

Market Analysis:
The global Ocular Drug Delivery market size is estimated to be worth USD26590 million in 2022 and is forecast to a readjusted size of USD35220 million by 2028 with a CAGR of 4.8% during the review period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Ophthalmic Pathology

The disease's diagnosis is crucial to the patient's treatment. Ophthalmic pathologists can give a tissue diagnosis as well as information on the cause, pathophysiology, and prognosis of ocular illnesses to practising ophthalmologists. In the discipline of ophthalmology, ophthalmic pathology has a long and illustrious history. Ocular pathologists use normal general pathology techniques to make clinical diagnosis from surgically excised tissue, which include gross inspection, routine histopathology, and specific stains. Ocular pathologists are uniquely qualified to apply their expertise to numerous disciplines of research due to their deep knowledge of the basic anatomy and physiology of the eye. Many notable research contributions by eye pathologists have led to the creation of ophthalmic gadgets, medicinal medicines, and surgical techniques.

•   Pathophysiology
•   Development and malformation
•   Wound healing and trauma
•   Inflammation
•   Advancements

Market Analysis:
The Global Pathology Consumables Market to grow at a CAGR of 6.85% during the period 2022-2023.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Ophthalmology Surgery

Surgical ophthalmology refers to ophthalmologists who undertake microsurgical intraocular procedures like cataract extraction and retinal detachment repair. The eye is a delicate organ that requires special attention before, during, and after surgery to minimise or avoid further injury. An professional eye surgeon is in charge of determining the best surgical procedure for the patient and ensuring that all necessary safety precautions are taken. Eye surgery is mentioned in a number of ancient books dating back to 1800 BC, with cataract therapy beginning in the fifth century BC. Today, many ways for treating eye issues have been developed, and it is still a widely done type of surgery.

•   Cataract and refractive surgery
•   Preparation and Precautions
•   Vitreoretinal surgery
•   Oculoplastics
•   Orbital/lacrimal disorders

Market Analysis:
The "Ophthalmology Surgery Devices Market" Size is expected to grow from 6443.5 million USD In 2020, to reach 6601.6 Million USD by 2026.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Optometry

Optometry is a health-care profession that focuses on checking the eyes for vision problems and diagnosing and treating them. Optometrists are professionals who help people with their eyesight, eye health, and overall wellness. They are trained to diagnose, treat, and rectify problems and diseases of the visual system, the eye, and the tissues that surround it. In a tertiary eye care hospital, optometrists also work as vision science researchers. Optometry is a tremendous tool for making a difference in people's lives.

•   Refractive Error Study
•   Visual Optics
•   Optometric Instruments
•   Mechanical Optics
•   Optic Dispensation

Market Analysis:
The Optometry market revenue was Million USD in 2016, grew to Million USD in 2020, and will reach Million USD in 2026, with a CAGR of during 2021-2026.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Paediatric Ophthalmology

A variety of eye issues affect many children and newborn babies. The earlier these issues are identified and addressed, the better. Paediatric ophthalmology is concerned with the treatment of children's eye issues. Paediatric ophthalmology aids in the early detection of vision disorders in children. If not addressed within six months of birth, an eye defect can leave a kid blind for the rest of his or her life. The reason for this is that the optic nerve is still developing during the first six months of life, and if eye problems are not addressed during this time, irreparable damage may result. Young children, too, might be affected by a variety of vision issues without ever realising it. This is why it's critical to include paediatric ophthalmology in your child's routine healthcare examinations.

•   Ophthalmoscope
•   Orthoptics
•   Refractive surgery
•   School vision screening
•   Visual acuity

Market Analysis:
It is valued at 119700 million USD in 2018 and will reach 159600 million USD by the end of 2025, growing at a CAGR of 3.7% during 2019-2025.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Pharmacology

The eye is a highly specialised organ that can suffer from a wide variety of diseases. Topical and systemic formulations are the least invasive ways for ocular drug administration. The corneal and conjunctival tissue layers are also important variables that limit medication distribution. Bioavailability is increased by using carriers that improve viscosity or bind to the ocular surface. Greater penetration is achieved by matching the pH and polarity of medication molecules to the tissue layers.

Ocular Pharmacokinetics
Ocular Pharmacodynamics
Molecular and cellular mechanisms of drug action
Molecular diagnostics
Drug interactions

Market Analysis:

The global market for Drug Discovery Technologies estimated at US$53.3 Billion in the year 2021, is projected to reach a revised size of US$80.2 Billion by 2026, growing at a CAGR of 8.1% over the analysis period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Regenerative Medicine

The ability of revolutionary therapies to treat a number of disorders, ranging from AMD to congenital degenerations, is being studied. A lot of firms are looking into using regenerative medicine to treat eye disorders. Stem cell delivery technologies have vastly improved, paving the possibility for more stem cell use. To replace or enhance the body's natural healing process, regenerative medicine uses diverse combinations of specially generated cells, tissues, and laboratory-made chemicals. Regenerative Medicine is expected to have an impact on the health-care business equivalent to that of antibiotics, vaccines, and, more recently, monoclonal antibodies in clinical care. Regenerative medicine is steadily progressing, but there are still many obstacles to overcome.

•   Cell Therapy
•   Transplantation
•   Stem Cell
•   Types
•   Approaches and Challenges

Market Analysis:
The global regenerative medicine market reached a value of US$ 14.78 Billion in 2021 and expecting to reach US$ 50.44 Billion by 2027, exhibiting a CAGR of 22.6% during 2022-2027.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Retina

The retina is an important part of your vision. It's a thin tissue that lines the rear of the eye's inner surface. When your retinas are unhealthy, they are unable to provide clear signals to the brain, resulting in vision loss or impairment. Comprehensive eye exams can discover retinal issues early on, allowing you to prevent catastrophic diseases and complications. Retinal research looks on new ways to treat some of the most critical eye diseases.

•   Types
•   Anatomy
•   Vision
•   Disorders
•   Diagnosis and Treatment

Market Analysis:
The Global Retina Market is expected to grow by $ 9.43 bn during 2022-2026, progressing at a CAGR of 12.54% during the forecast period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Retinal Cell Biology

The layers of Retina are laminated. The outer nuclear layer is made up of the nuclei of photoreceptors (ONL). The inner nuclear layer (INL) contains the nuclei of bipolar cells, amacrine cells, horizontal cells, and Müller glial cells, whereas the ganglion cell layer contains the nuclei of ganglion cells (GCL). The processes and synaptic terminals of photoreceptors, horizontal cells, and bipolar cells are found in the outer plexiform layer (OPL). The processes and terminals of bipolar cells, amacrine cells, and ganglion cells are found in the inner plexiform layer (IPL). Müller glial cells' processes take up all of the area in the retina that isn't taken up by neurons or blood vessels.

•   Vision Molecular Biology
•   Visual Physiology
•   Retinal Function and Dysfunction
•   Retinal Pathophysiology
•   Therapeutic Development

Market Analysis:
Retinal biologics market revenue totaled US$ 19.96 Bn in 2021. The global market is expected to reach US$ 41.92 Bn by 2028, surging at a CAGR of 11.1% over the period of 2022-2028.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Retinal Imaging

Retinal imaging is the process of taking a digital image of the back of your eye. The retina (where light and images are reflected), the optic disc (a region on the retina that houses the optic nerve, which transmits information to the brain), and blood arteries are all depicted. Your optometrist can observe your eyes more closely and precisely with retina imaging. The retinal imaging exam is quick and painless, and the findings are available practically instantly. Furthermore, the photographs created are saved and can be simply compared to subsequent images. Over time, retinal imaging has improved as a result of ongoing study and development. There are some limits to retinal imaging.

•   Types
•   Benefits
•   Techniques
•   Risks
•   Methods

Market Analysis:
The Global Retinal Imaging Devices Market is poised to value over USD 6.8 billion by 2027 end at a CAGR of over 6.4% during the forecast period 2020 to 2027.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Spatial Vision

The process of detecting and classifying simple sinusoidal patterns is known as spatial vision. Our contrast sensitivity function describes our spatial vision capacity. Various factors influence this sensitivity, including the observer's optical, retinal, neurological, and adaptive condition. Details are best perceived when they are imaged on the foveal (i.e., centre) parts of the retina in human spatial vision. Peripheral vision, on the other hand, provides a wealth of useful visual information. This data is utilised to direct eye movements and attention, improve depth and motion perception, and maintain balance and postural stability.

•   Spatial acuity
•   Temporal Vision
•   Contrast Sensitivity
•   Spatial Frequency
•   Visual Perception

Market Analysis:
It is poised to grow by $ 10.19 bn during 2022-2026, progressing at a CAGR of 13.76% during the forecast period.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Translational Research

Translational research utilises scientific findings generated in the lab, clinic, or field and turns them into novel treatments and medical care practises that benefit the general public's health. It is usually called bench to bedside – refers to the application of findings from basic research to the development and testing of preventative and treatment interventions (i.e. services, programmes, behaviours, and products) and vice versa. Translational research is patient-centered and refers to a method of health research that involves a continuous exchange of basic and applied knowledge. As a result, clinical research excellence is a critical component of effective translational research.
•   Laser-tissue interactions
•   Advanced diagnostics and imaging
•   Prosthetic vision
•   Retinal plasticity
•   Retinal Pathologies

Market Analysis:
The global Translational Regenerative Medicine market was valued at 10.96 Million USD in 2021 and will grow with a CAGR of 12.57% from 2021 to 2027.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Uveitis Scleritis

Uveitis is an infection of the eye's middle layer, which contains many of the eye's blood vessels, whereas Scleritis is an inflammation of the white component of the eye. Scleral inflammation that extends to the anterior uveal tract is a sign of a more serious condition with ocular consequences that can lead to progressive vision loss. When anterior uveitis develops throughout the course of scleritis, the ocular prognosis is poor. The severity of scleritis-related uveitis ranged from mild to moderate, and it was always linked to active scleritis.
•   Types
•   Symptoms
•   Diagnosis and Management
•   Risk Factors
•   Medical Conditions

Market Analysis:
The Uveitis Treatment Market Size is expected to grow from 414.9 million USD In 2020 to reach 544.7 Million USD by 2026 at 4.6% CAGR.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Vision Therapy

Vision therapy (VT) is a sub-specialty of developmental optometry that uses a prescribed treatment programme to construct and establish new brain patterns to improve, enhance, and develop visual function. Many common visual issues, such as lazy eye (amblyopia), crossed eyes (strabismus), double vision, convergence insufficiency, and vision impairments that interfere with learning, can be treated with vision therapy. Consider vision therapy as a sort of physical therapy for the eyes and brain to have a better understanding. Physical therapy allows you to relearn or improve the utilisation of muscles and body parts that aren't working properly. Eye teaming, tracking, convergence, visual perception, eye-hand coordination, and visual motor integration are all re-learned or improved in vision therapy. Because vision is a learnt process, this is conceivable.

•   Therapy
•   Role of optometrist
•   Behavioral Optometry
•   Treatment Types
•   Benefits

Market Analysis:
The global vision care market size reached US$ 66.5 Billion in 2021. Looking forward, the market expects to reach US$ 83.2 Billion by 2027, exhibiting at a CAGR of 3.7% during 2022-2027.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Vitreous Disorders

Vitreoretinal disorders are ailments that affect the retina and vitreous, two components in the eye. The retina is a light-sensitive layer at the back of the eye that concentrates images and sends them to the brain via the optic nerve. The vitreous covers the area between the lens (at the front of the eye) and the retina with a clear gel. Vitreoretinal diseases are treated using the latest diagnostic tools and on-site imaging by eye specialists.

•   Macular Degeneration
•   Retinal Vein Occlusion
•   Vitreous Detachments
•   Cystoid Macular Edema
•   Vitreomacular Adhesion

Market Analysis:
The Global Vitreous Tamponades Market is estimated to reach over USD 96.77 billion by 2028 end at a CAGR of over 3% during the forecast period 2021 to 2028.

Tags

Max Seats
15 seats
Speaker Time
20 mins
Workshop Proposal
Click Here

Scope & Importance

Scope & Importance

Ophthalmology is the branch of medicine that deals with anatomy, physiology, disease and treatment of eye related issues. These issues can include dealing with or treating problems of the eye like glaucoma, nearsightedness, farsightedness, blindness, cataracts and macular degeneration through the use of surgery or laser technology. To identify further research and investigate new technology or surgical tools uses to treat diseases. Industry research and market reports address research used to treat patients and provide therapeutic care. To educate and enable smart business decision on pharma companies involved in the ophthalmology.

Novel Ophthalmology Market Overview

The Global Eye Care Products Market is estimated to grow from USD 61.3 million in 2020 to USD 79.9 million by 2026 at a healthy CAGR of 4.6% during the forecast period.

The ophthalmology drug and device market is expected to witness a CAGR of 5.5% during the forecast period.

The Ophthalmology Surgical Devices Market studied was anticipated to grow with a CAGR of nearly 5.5% during the forecast period. The major factors driving the growth of the market are the global prevalence of various ophthalmic disorders such as glaucoma, cataract, and diabetic retinopathy and rise in the geriatric population resulting in the global burden of avoidable blindness.

At 3.1% CAGR, The "Cataract Surgery Device Market" Size is expected to grow from 3524.3 million USD In 2020, to reach 3643.2 Million USD by 2026, The base year considered for the study is 2021, and the forecast period is between 2022 and 2026.

The glaucoma market is expected to grow from $2.85B in 2020 to $3.48B in 2030, a CAGR of 2%. The US is the biggest market of the 7MM, accounting for 75.0% market share in 2020. This is set to increase to 80.2% by 2030.

Novel Ophthalmology Market Overview in USA

The global cataract surgical devices market size is expected to reach US$ 10.66 Billion by 2027, exhibiting at a CAGR of 4.48% during 2022-2027.
Glaucoma Treatment Market size exceeded USD 5.5 billion in 2021 and is expected to witness over 3.2% CAGR from 2022 to 2028.

The size of the Diabetic Retinopathy was worth USD 2.60 billion in 2022 and is projected to reach USD 3.49 billion by 2027, growing at a CAGR of 6.05% during the forecast period.

The North America Ophthalmic Devices & Drugs Market is expected to grow with a CAGR of 5% during the forecasted period. Certain factors that are driving the growth of the market include demographic shift, the impact of the prevalence of eye disease, technological advancements in the field of ophthalmology, and rising geriatric population. The aging population is expected to burden all areas of healthcare, and ophthalmologists provide approximately 90% of their procedure-based services to seniors. There has been a rising prevalence of eye diseases, such as glaucoma, cataract, macular degeneration, and diabetic retinopathy in North American countries. For instance As per the statistics published by National Eye Institute, currently, around 1.3 million Americans are blind, and 2.9 million have low vision. An estimated 2.2 million Americans may face vision loss, and 5 million will have low vision by 2030. Hence, an increase in eye disorders will lead to the growing demand for drugs and devices.

The Ophthalmology Device Market size in North America has been projected at USD 16.55 Billion in 2022. It is estimated to reach USD 21.23 Billion markets by 2027, growing azt a compound annual growth rate (CAGR) of 5.1% between 2022 to 2027.

Novel Ophthalmology Market Overview in Europe

The Europe Primary Angle-Closure Glaucoma Market is expected to growing with a CAGR of 6.1% in the forecast period of 2022 to 2029.

The global Cataract Surgical Devices market size is estimated to be worth USD 7784.1 million in 2022 and is forecast to a readjusted size of USD 10070 million by 2028 with a CAGR of 4.4% during the review period.

Ophthalmology Device Market in the United Kingdom is expected to grow, due to the rising number of eye-related diseases and disorders, and greater awareness among people. According to the Royal National Institute of Blind People, as of 2017, there are around 350,000 people on the registers of blind and partially sighted people in the UK. A total of 173,735 are registered severely sight impaired and 176,125 are registered sight-impaired.

Further, the development of new ophthalmology devices and advanced techniques are favouring the growth of the market. Although the ophthalmology devices market displays great promise, due to the increasing number of eye problems, it still faces barriers, such as the risk associated with surgical procedures of the eye which might impede the growth of the market.

The size of the Diabetic Retinopathy Market in Europe has been estimated at USD 1.34 billion in 2022. It is projected to reach USD 1.84 billion by 2027, at a CAGR of 6.55% during the forecast period. Diabetic retinopathy is a medical condition which damages the retina and leads to blindness if untreated or undiagnosed.

Novel Ophthalmology Market Overview in Middle East

The Middle East and Africa Ophthalmology Devices Market size have been estimated at USD 4.04 Billion in 2022 and to grow USD 5.27 Billion by the end of 2027, growing at a CAGR of 5.46% between 2022 to 2027.

At 6.1% CAGR, The "Retinal Surgery Devices Market" Size is expected to grow from 1533 million USD In 2020, to reach 2328 Million USD by 2026, The base year considered for the study is 2021, and the forecast period is between 2022 and 2026. Retinal Surgery Devices Market 2022 Research Report provides key analysis on the market status of the Retinal Surgery Devices manufacturers with best facts and figures, meaning, definition, SWOT analysis, expert opinions and the latest developments across the globe.

The size of the Middle East and Africa Diabetic Retinopathy Market was valued at USD 0.75 Billion in 2022 and is predicted to be worth USD 1.04 Billion by 2027, at a CAGR of 6.86% during the forecast period.

Middle East and Africa micro invasive glaucoma surgery (MIGS) devices market is projected to register a substantial CAGR of 23.9% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

The Glaucoma Treatment Market is forecasted to reach a net worth of US$ 7.6 Bn in 2032 from US$ 5.5 Bn in 2021 by registering a moderate CAGR of 3%. With the increasing proportion of the geriatric population in different geographic regions, glaucoma has emerged as a prevalent ailment.

Novel Ophthalmology Market Overview in Asia Pacific

The market in Asia-Pacific for ophthalmology drugs and devices is expected to grow with a CAGR of 6.41% during the forecast period from 2019 to 2027.

The Indian glaucoma and cataract surgery devices market was valued at $164 million in 2016, and is expected to reach $321 million by 2023, registering a CAGR of 10.1% from 2017 to 2023.

The size of the diabetic retinopathy market in the Asia Pacific was valued at USD 1.80 billion in 2022 and is projected to reach USD 2.64 billion by 2027, growing at a CAGR of 7.94% during the forecast period.

Asia is predicted to show wealthy growth in the forecast period. Within the Asian region, the western pacific region accounts for a larger share of blindness due to DR when equated to South-East Asia.

Target Audience

•   Ophthalmologists
•   Optometrists
•   Researchers
•   Eye surgeons
•   Physicians
•   Eye care specialists
•   Professors and Doctors
•   Delegates and Students
•   Members of Ophthalmology Societies and Associations
•   Directors/Co-Directors of Research-based companies
•   Business professionals (Directors, Presidents, CEO) from Ophthalmology equipment companies.

Ophthalmology Societies in USA: